Edwards Comments on German Appellate Court Ruling
(firmenpresse) - IRVINE, CA -- (Marketwired) -- 11/14/13 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today said that an appeals court in Germany has suspended the enforcement of an injunction against sales of Medtronic's transcatheter heart valves in Germany, pending the posting of a EUR 5 million bond by Medtronic. This action comes after the European Patent Office (EPO) issued a non-binding preliminary opinion in October indicating concerns about the validity of the Edwards Spenser patent.
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring, enabling them to save and enhance lives. Additional company information can be found at .
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.
Sarah Huoh
949-250-5070
David K. Erickson
949-250-6826
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.11.2013 - 21:52 Uhr
Sprache: Deutsch
News-ID 316902
Anzahl Zeichen: 0
contact information:
Town:
IRVINE, CA
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 277 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Edwards Comments on German Appellate Court Ruling"
steht unter der journalistisch-redaktionellen Verantwortung von
Edwards Lifesciences (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
